Salient Surgical Technologies
Founded Year
1999Stage
Acquired | AcquiredTotal Raised
$126.05MValuation
$0000Revenue
$0000About Salient Surgical Technologies
Salient Surgical (formerly TissueLink) is a medical device company commercializing radio-frequency electrosurgical instruments for orthopedic, spine, and general surgery.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Salient Surgical Technologies Patents
Salient Surgical Technologies has filed 15 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/21/2008 | 7/10/2012 | Surgical instruments, Surgery, Surgical removal procedures, Surgical procedures and techniques, Medical equipment | Grant |
Application Date | 3/21/2008 |
|---|---|
Grant Date | 7/10/2012 |
Title | |
Related Topics | Surgical instruments, Surgery, Surgical removal procedures, Surgical procedures and techniques, Medical equipment |
Status | Grant |
Latest Salient Surgical Technologies News
Jul 8, 2011
Reprints Medical device giant Medtronic said it will acquire Salient Surgical Technologies in Portsmouth, NH for $525 million. Established in 1999 and formerly known as Tissuelink Medical , Salient makes devices that stop bleeding and seal wounds by allowing surgeons to apply focused radio-frequency energy and saline solution to collagen fibers in the body. Given Medtronic’s previous ownership stake in Salient, the actual price tag will be $480 million. Previous investors in Salient include Piper Jafray Ventures, Arnerich Messina & Associates, and Rivervest Venture Partners.
Salient Surgical Technologies Frequently Asked Questions (FAQ)
When was Salient Surgical Technologies founded?
Salient Surgical Technologies was founded in 1999.
Where is Salient Surgical Technologies's headquarters?
Salient Surgical Technologies's headquarters is located at 180 International Drive, Portsmouth.
What is Salient Surgical Technologies's latest funding round?
Salient Surgical Technologies's latest funding round is Acquired.
How much did Salient Surgical Technologies raise?
Salient Surgical Technologies raised a total of $126.05M.
Who are the investors of Salient Surgical Technologies?
Investors of Salient Surgical Technologies include Medtronic, RiverVest Venture Partners, QuestMark Partners, TLM Investors, Arnerich Massena & Associates and 14 more.
Who are Salient Surgical Technologies's competitors?
Competitors of Salient Surgical Technologies include AlterG, Paragon Medical, Celula, Sterilmed, TransCorp and 12 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare Salient Surgical Technologies to Competitors
NIR Diagnostics is developing a diagnostic device to quantitatively assess the progress of the wound healing process. Per the company, the device has the potential to be a more accurate, more rapid, and less expensive method of wound assessment compared to those currently on the market.
Dornier Medtech America is a medical device company. It had developed the Medilas D Family Lasers, Including Medilas D Litebeam, Litebeam +, Urobeam, Multibeam, Flexipulse And Magnapulse.Dornier MedTech develops, manufacturers, markets and services lithotripters, orthopedic shock wave devices, urotables and medical aesthetic lasers worldwide, providing innovative therapeutic, diagnostic and service solutions for numerous healthcare fields. Dornier MedTech invented extracorporeal shockwave lithotripsy, (ESWL), more than 25 years ago for the disintegration of kidney stones, which is today the gold standard for urinary stone treatment.
Moximed develops unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA). The company offers an implant procedure that do not require bone cutting or bone removal, and, importantly, they absorb excess joint load rather than shift load to other areas of the joint. The company was founded in 2006 and is based in Fremont, California.
E-Pill Pharma - Develops an "electrical pill" performing electrical nerve stimulation of the intestines (ENSI). ENSI affects the absorption properties of the GI tract membrane.
Advanced Medical Diagnostics appoints Imaging Equipment Ltd as commercial agent for Prostate HistoScanning in the UK and Ireland.
Palyon Medical is a preclinical-stage medical device company focused on a spin-based drug delivery system.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
